BRENDA PIGANELLI: Open Payments
NPI 1184661795 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 9 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $1,369 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $223 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $167 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $119 |
| Hologic Sales and Service, LLC | 1 | $89 |
| Paratek Pharmaceuticals, Inc. | 1 | $54 |
Products named: REXULTI, GATTEX, MOUNJARO, APTIMA, NUZYRA.
Industry payments across TX — which companies pay providers there.
